2-deoxyglucose AUC | None | | 0 to ∞ | None | |
acetoacetate oxidation | ACT OX | (µMol/min/g) | -∞ to ∞ | None | |
Activity (hourly) | Activity-hourly | (beam breaks/h) | 0 to ∞ | U Mass - Energy balance – food intake, energy expenditure, physical activity | |
Activity 24h (total vertical z-axis) | Activity 24h total z | (beam breaks/24h) | -∞ to ∞ | None | |
Activity 24h (total x-axis) | Activity 24h total x | (beam breaks/24h) | -∞ to ∞ | None | |
Activity 24h (total) | Activity 24h (total) | (beam breaks/24h) | 0 to ∞ | U Mass - Energy balance – food intake, energy expenditure, physical activity | |
Activity 24h (x-ambulatory) | Activity 24h (x-amb) | (beam breaks/24h) | -∞ to ∞ | None | |
adenosine diphosphate | adp | | -∞ to ∞ | None | |
adenosine monophosphate | AMP | | -∞ to ∞ | None | |
adenosine triphosphate | ATP | | -∞ to ∞ | None | |
adiponectin | None | (mg/dL) | -∞ to ∞ | None | |
adiponectin, High Molecular Weight | adiponectin HMW | | 0 to 100 | None | |
adiponectin, total | adiponectin total | (µg/ml) | 0 to 100 | None | |
Adrenocorticotropic hormone | ACTH | (pg/ml) | 0 to ∞ | None | |
Age | None | (w) | 0 to 1092 | None | |
Akt, phosphorylated | Akt phosphorylated | (AU) | 0 to 10000 | None | |
Akt, total | Akt total | (AU) | 0 to 10000 | None | |
alanine | None | | 0 to ∞ | None | |
alanine aminotransferase | ALT | (U/L) | 0 to ∞ | None | |
Alanine transaminase, blood | None | | 0 to ∞ | U Mass - Alanine Transferase | |
albumin | None | (g/dL) | -∞ to ∞ | None | |
albumin, blood | None | | 0 to ∞ | None | |
alkaline phosphatase | ALP | (U/L) | 0 to ∞ | None | |
alkaline phosphatase, blood | None | | 0 to ∞ | None | |
alpha ketoglutarate glutamate exchange rate | Vx | (µMol/min/g) | -∞ to ∞ | None | |
alternating triplets - percent | % triplets | (%) | 0 to 100 | UC Davis - Y-Maze | |
amino acids, branched-chain | None | | 0 to ∞ | None | |
amino acids, essential | None | | 0 to ∞ | None | |
amino acids, gluconeogenic | None | (U/L) | -∞ to ∞ | None | |
amino acids, glyconeogenic | glyconeogenic AA | | 0 to ∞ | None | |
amino acids, nonessential | None | | 0 to ∞ | None | |
ammonia | ammonia | (µmol/l) | -∞ to ∞ | None | |
anaplerosis | None | (µMol/min/g) | -∞ to ∞ | None | |
Angiotensin II | Angiotensin II | (ng/ml) | 0 to 1000 | None | |
antibody | None | | -∞ to ∞ | None | |
antigen | None | | -∞ to ∞ | None | |
Aortic atherosclerosis area, abdominal | None | (%) | -∞ to ∞ | None | |
Aortic atherosclerosis area, thoracic | None | (%) | -∞ to ∞ | None | |
Aortic atherosclerosis area, total | None | (%) | -∞ to ∞ | None | |
aortic diameter, abdominal | None | (mm) | -∞ to ∞ | None | |
aortic lesion complexity index | LCI | | -∞ to ∞ | None | |
aortic pressure, mean | None | (mmHg) | -∞ to ∞ | None | |
apolipoprotein A | None | (mg/dL) | -∞ to ∞ | None | |
apolipoprotein B | None | (mg/dL) | -∞ to ∞ | None | |
apolipoprotein C3 | ApoC3 | (mg/dL) | 0 to 800 | None | |
aspartate | None | | 0 to ∞ | None | |
aspartate aminotransferase | AST | (U/L) | 0 to ∞ | None | |
Assay Respiratory Control | RC | | -∞ to ∞ | None | |
average aortic lesion area | AALA | (µm²) | 0 to ∞ | None | |
average clamp glucose | None | (mg/dL) | -∞ to ∞ | None | |
average glucose infusion rate | None | (mg/kg/min) | -∞ to ∞ | None | |
beta-hydroxybutyrate | None | (µmol/l) | -∞ to ∞ | None | |
beta-oxidation index | b-Ox index | (µMol/min/g) | -∞ to ∞ | None | |
bicarbonate | None | (mEq/L) | -∞ to ∞ | None | |
bilirubin | None | (mg/dL) | -∞ to ∞ | None | |
bilirubin, direct | None | (mg/dL) | -∞ to ∞ | None | |
bilirubin, Total | total bilirubin | (mg/dL) | 0 to ∞ | None | |
blood flow, % | None | (%) | -∞ to ∞ | None | |
blood pressure, mean arterial | None | (mmHg) | -∞ to ∞ | None | |
blood pressure: diastole | dBP | (mmHg) | 0 to ∞ | Phenotypic Characterization of the Working Heart | |
blood pressure: mean arterial | aBP | (mmHg) | -∞ to ∞ | None | |
blood pressure: systole | sBP | (mmHg) | 0 to ∞ | Phenotypic Characterization of the Working Heart | |
body mass | W rodent | (g) | 0 to 100 | None | |
body water | body fluid | (g) | -∞ to ∞ | None | |
body water, absolute amount | None | (g) | -∞ to ∞ | None | |
body water, free | free water | (g) | -∞ to ∞ | None | |
bone area | bone area | (cm²) | -∞ to ∞ | None | |
bone mineral content | BMC | (g) | -∞ to ∞ | None | |
bone mineral density | BMD | (g/cm²) | -∞ to ∞ | None | |
Bout Distance, Average | Avg Bout Distance | (m/bout) | 0 to 500 | None | |
Bout Time, Average | Avg Bout Time | (min/bout) | 0 to 20 | None | |
Bouts | Bouts | (unitless) | 0 to 1000 | None | |
brain mass | brain wt | (g) | 0 to 3 | None | |
C-peptide | C-peptide | (ng/ml) | -∞ to ∞ | None | |
c-reactive protein | CRP | (ng/ml) | 0 to 25000 | None | |
calcium | None | (mg/dL) | -∞ to ∞ | None | |
calcium, blood | None | (mg/dL) | 0 to ∞ | None | |
calcium, urine | urine calcium | (mg/dL) | 1 to 15 | None | |
carbon dioxide production | VCO2 | (CO2/kg/hr) | -∞ to ∞ | None | |
carbon dioxide production Dark Period | VCO2-D | (CO2/kg/hr) | -∞ to ∞ | None | |
carbon dioxide production Light Period | VCO2-L | (CO2/kg/hr) | -∞ to ∞ | None | |
carbon dioxide, blood | None | | 0 to ∞ | None | |
cardiac ejection fraction | None | (%) | 0 to 100 | None | |
cardiac function, intraventricular pressure: diastole | None | (mmHg) | -∞ to ∞ | None | |
cardiac function, intraventricular pressure: end diastole | None | (mmHg) | -∞ to ∞ | None | |
cardiac function, intraventricular pressure: systole | None | (mmHg) | -∞ to ∞ | None | |
cardiac output | None | | 0 to ∞ | None | |
cardiac venous return | None | (ml/min) | -∞ to ∞ | None | |
Catalase Activity | CAT Activity | (nmol/min/ml) | 0 to 5000 | None | |
Catalase Activity - protein | CAT Activity - prot | (nmol/min/mg protein) | 0 to 5000 | None | |
CCL11 | Eotaxin | (pg/ml) | -∞ to ∞ | None | |
CCL21 | Exodus-2 | (pg/ml) | 0 to ∞ | None | |
chloride concentration | None | (U/kg) | -∞ to ∞ | None | |
chloride, blood | None | | 0 to ∞ | None | |
chloride, urine | urine chloride | (µmol/l) | 0 to ∞ | None | |
cholesterol | None | (mg/dL) | -∞ to ∞ | None | |
cholesterol concentration in low density lipoproteins | None | (mg/dL) | -∞ to ∞ | None | |
cholesterol concentration in very low density lipoproteins | None | (mg/dL) | -∞ to ∞ | None | |
cholesterol remaining in intestinal lumen | None | (%) | -∞ to ∞ | None | |
cholesterol remaining in intestinal lymph | None | (%) | -∞ to ∞ | None | |
cholesterol remaining in intestinal mucosa | None | (%) | -∞ to ∞ | None | |
Cholesterol transported in lymph | Cholesterol in lymph | (%) | -∞ to ∞ | None | |
cholesterol, CM, plasma | CM-cholesterol | (mg/dL) | 0 to 10000 | None | |
cholesterol, fractional clearance rate | CHOL FCR | (min) | -∞ to ∞ | None | |
cholesterol, HDL | None | (%) | -∞ to ∞ | None | |
cholesterol, HDL (COBAS) | HDL-COBAS | (mg/dL) | 0 to ∞ | None | |
cholesterol, HDL (UC) | HDL-UC | (mg/dL) | 0 to ∞ | Ultracentrifugal separation of VLDL, LDL and HDL | |
cholesterol, HDL, plasma | HDL-cholesterol | (mg/dL) | -∞ to ∞ | None | |
cholesterol, HDL, triglycerides, plasma | HDL-TG | (mg/dL) | -∞ to ∞ | None | |
Cholesterol, Hepatic Uptake | Hepatic CHOL uptake | (%) | -∞ to ∞ | None | |
cholesterol, LDL and VLDL | LDL/VLDL | (mg/dL) | 0 to 5000 | None | |
cholesterol, LDL, plasma | LDL-cholesterol | (mg/dL) | -∞ to ∞ | None | |
cholesterol, newly synthesized | new cholesterol | (%) | 0 to 100 | None | |
cholesterol, splenic uptake | Splenic CHOL uptake | (%) | -∞ to ∞ | None | |
cholesterol, TG-bound new | TG-bound cholesterol | (umol new/g tissue) | -∞ to ∞ | None | |
cholesterol, TG-bound total | TG-bound cholesterol | (umol total/g tissue) | -∞ to ∞ | None | |
cholesterol, tissue | cholesterol (tissue) | (mg/g tissue) | -∞ to ∞ | None | |
cholesterol, total | TC | (mg/dL) | 0 to ∞ | Lipid Profiles in Mice | |
cholesterol, vLDL, plasma | VLDL-cholesterol | (mg/dL) | -∞ to ∞ | None | |
cholesteryl ester fatty acids | None | (%) | 0 to 100 | None | |
cholesteryl ester in chylomicrons | CE-CM | (% wt/wt) | -∞ to ∞ | None | |
cholesteryl esters | None | (µg/mg) | 0 to ∞ | None | |
chylomicrons | None | (%) | -∞ to ∞ | None | |
citrate flux rate | None | (µMol/min/g) | -∞ to ∞ | None | |
citrate synthase flux rate | citrate synthase FR | | -∞ to ∞ | None | |
CoA ester, C16:0 | None | (nmol/g-tissue) | -∞ to ∞ | None | |
CoA ester, C16:1 | None | (nmol/g-tissue) | -∞ to ∞ | None | |
CoA ester, C18:0 | None | (nmol/g-tissue) | -∞ to ∞ | None | |
CoA ester, C18:1 | None | (nmol/g-tissue) | -∞ to ∞ | None | |
CoA ester, C18:2 | None | (nmol/g-tissue) | -∞ to ∞ | None | |
CoA ester, C18:3 | None | (nmol/g-tissue) | -∞ to ∞ | None | |
CoA ester, total | TotalCoA | (nmol/g-tissue) | 0 to ∞ | None | |
CoA esters, long-chain | None | (nmole) | -∞ to ∞ | None | |
Complete Alternations | CA | (TPD) | -∞ to ∞ | None | |
Complexes | None | (bpm) | 0 to ∞ | None | |
corticosterone | None | (ng/ml) | -∞ to ∞ | None | |
corticosterone, plasma, arterial | None | (µg/mg) | 0 to ∞ | None | |
creatine kinase | creatine kinase | (U/L) | 0 to ∞ | None | |
creatinine, blood | blood creatinine | (mg/dL) | 0 to ∞ | None | |
creatinine, plasma | plasma cre | (mg/dL) | 0 to ∞ | None | |
creatinine, serum | SCR | (mg/dL) | 0 to ∞ | None | |
creatinine, urine (Exocell Picric Acid method) | ucreat | (mg/dL) | 0 to ∞ | None | |
creatinine, urine (spot) | ucreatinine-spot | (mg/dL) | -∞ to ∞ | None | |
creatinine, urine, 24h (HPLC) | UCreat-HPLC | (mg/dL) | -∞ to ∞ | None | |
CX3CL1 | Fractalkine | (pg/ml) | 0 to ∞ | None | |
De novo lipogenesis, white adipose tissue-gonadal | DNL-gonadal-WAT | (dpm/mg) | -∞ to ∞ | None | |
De novo lipogenesis, white adipose tissue-inguinal | DNL-inguinal-WAT | (dpm/mg) | -∞ to ∞ | None | |
De novo lipogenesis, white adipose tissue-perirenal | DNL-perirenal-WAT | (dpm/mg) | -∞ to ∞ | None | |
De novo lipogenesis, white adipose tissue-subcutaneous | DNL-subcu-WAT | (dpm/mg) | -∞ to ∞ | None | |
diacyglycerols | None | (µg/mg) | 0 to ∞ | None | |
diacylglycerol fatty acids | None | (%) | 0 to 100 | None | |
Distance in Open Field Zone | Distance in OFZ | (cm) | 0 to 20000 | None | |
Distance run | Distance run | (m) | 0 to 20000 | None | |
DR | D | | -∞ to ∞ | None | |
duration of recording | None | (min) | 0 to ∞ | None | |
Duration run | Duration run | (min) | 0 to 720 | None | |
eating rate, average | avg eating rate | (g/min) | 0 to ∞ | None | |
eating rate, dark | dark-eating rate | (g/min) | 0 to ∞ | None | |
eating rate, light | light-eating rate | (g/min) | 0 to ∞ | None | |
EKG-Beginning to end of QRS complex | EKG-QRS | (msec) | -∞ to ∞ | None | |
EKG-Interval between R-waves | EKG-RR | (msec) | -∞ to ∞ | None | |
EKG-Interval between the peak of P-wave to Q-wave | EKG-PQ | (msec) | -∞ to ∞ | None | |
EKG-Interval between the peak of P-wave to R-wave | EKG-PR | (msec) | -∞ to ∞ | None | |
EKG-Interval between the peak of Q-wave to end of T-wave | EKG-QT | (msec) | -∞ to ∞ | None | |
EKG-Interval between the peak of S-wave to end of T-wave | EKG-ST | (msec) | -∞ to ∞ | None | |
EKG-Rate-corrected QT | EKG-QTc | (msec) | -∞ to ∞ | None | |
endurance time | None | (min) | 0 to ∞ | None | |
energy expenditure | None | (kcal/hr/kg) | -∞ to ∞ | None | |
energy expenditure, 30 min exercise | None | | 0 to ∞ | None | |
energy expenditure, basal | None | | 0 to ∞ | None | |
energy expenditure, exhaustion | None | | 0 to ∞ | None | |
energy expenditure, maximum | None | | 0 to ∞ | None | |
energy intake (24 hr) | None | (Kcal/day) | -∞ to ∞ | None | |
energy intake (avg 24 hr) | energy intake avg 24 | (Kcal/day) | -∞ to ∞ | None | |
energy intake (Dark Period) | energy intake - dark | (Kcal/12h) | -∞ to ∞ | None | |
energy intake (Light Period) | food intake - light | (g/12h) | 0 to ∞ | None | |
energy intake (Ligth Period) | energy intake -light | (Kcal/12h) | -∞ to ∞ | None | |
epinephrine, plasma, arterial | None | | 0 to ∞ | None | |
Erythropoietin | EPO | (pg/ml) | 0 to ∞ | None | |
Estradiol | Estradiol | (pg/ml) | 0 to ∞ | None | |
exploratory activity | None | | 0 to ∞ | None | |
fat absorbtion, dietary | None | (%) | -∞ to ∞ | None | |
fat body mass | None | (g) | 0 to ∞ | None | |
fat tissue mass | None | (g) | -∞ to ∞ | None | |
fat tissue, % | % body fat | (%) | 0 to 100 | None | |
fat tissue, brown | BAT wt | (g) | 0 to 7 | None | |
fat tissue, epidymal | epidymal fat wt | (g) | 0 to 7 | None | |
fat tissue, mesenteric | Mesenteric Fat Wt | (g) | 0 to 7 | None | |
fat tissue, periovarian | PFD wt | (g) | 0 to 7 | None | |
fat tissue, retroperitoneal | retroperitoneal fat | (g) | 0 to 7 | None | |
fat tissue, subcutaneous | subcutaneous fat wt | (g) | 0 to 7 | None | |
Fecal Output | None | (g) | -∞ to ∞ | None | |
Fibroblast growth factor 21 | FGF-21 | (pg/ml) | 0 to 50000 | None | |
FITC-Dextran 4000 (FD4) flux | FD4 flux | (ng/cm2/h) | 0 to ∞ | UC Davis - Ex vivo assessment of barrier function-gut permeability | |
food intake | food intake | (g/day) | 0 to ∞ | None | |
food intake (Dark Period) | food intake - dark | (g/12h) | -∞ to ∞ | None | |
food intake to body weight ratio | food intake/bw | | 0 to ∞ | None | |
fractional shortening | None | | 0 to ∞ | Echocardiography: Mouse | |
free fatty acids, tissues | FFA tissue | (mEq/g tissue) | 0 to 100 | None | |
GABA and glutamate | None | | 0 to ∞ | None | |
Gamma-glutamyl Transpeptidase | GGT | (U/L) | 0 to 50 | None | |
ghrelin, active | ghrelin active | (pg/ml) | 0 to 1000 | None | |
ghrelin, total | ghrelin total | (pg/ml) | 0 to 10000 | None | |
GIP | GIP | (ng/ml) | -∞ to ∞ | None | |
glomerular filtration rate | GFR | (ml/min) | -∞ to ∞ | None | |
glucagon | None | (pg/ml) | -∞ to ∞ | None | |
glucagon, plasma, arterial | None | | 0 to ∞ | None | |
Glucagon-like peptide 1 | GLP-1 | (ng/ml) | -∞ to ∞ | None | |
glucagon-like peptide-1, active | GLP-1 active | (pg/ml) | 0 to 1000 | None | |
glucagon-like peptide-1, total | GLP-1 total | (pg/ml) | 0 to 1000 | None | |
gluconeogenesis | GNGtotal | (µMol/min/g) | -∞ to ∞ | None | |
gluconeogenesis from glycerol | GNGglycerol | (µMol/min/g) | -∞ to ∞ | None | |
gluconeogenesis from PEP | GNGpep | (µMol/min/g) | -∞ to ∞ | None | |
gluconeogenesis rate | None | (mg/kg/min) | 0 to ∞ | None | |
glucose appearance, endogenous | None | | -∞ to ∞ | None | |
glucose infusion rate | None | | -∞ to ∞ | None | |
glucose infusion rates | None | (mg/kg/min) | 0 to ∞ | None | |
glucose metabolic index, brain | None | | 0 to ∞ | None | |
glucose metabolic index, diaphragm | None | | 0 to ∞ | None | |
glucose metabolic index, gastrocnemius | None | | 0 to ∞ | None | |
glucose metabolic index, heart | None | | -∞ to ∞ | None | |
glucose metabolic index, soleus | None | | 0 to ∞ | None | |
glucose metabolic index, superficial vastus lateralis | None | | 0 to ∞ | None | |
glucose oxidation | None | (µMol/min/g) | -∞ to ∞ | None | |
glucose production | None | (µMol/min/g) | -∞ to ∞ | None | |
glucose rate of appearance, endogenous | endo RA | (mg/kg/min) | -∞ to ∞ | None | |
glucose rate of disappearance | None | | -∞ to ∞ | None | |
glucose synthesis | None | (nmol/min/g) | -∞ to ∞ | None | |
glucose tolerance test (AUC) | GTT-AUC | (mg/dl*min) | 10000 to 100000 | None | |
glucose turnover, whole body | None | (mg/kg/min) | -∞ to ∞ | None | |
Glucose turnover, whole body, specific activity (SA) | None | (dpm/mg) | -∞ to ∞ | None | |
glucose uptake | None | (nmol/min/g) | -∞ to ∞ | Glucose uptake in isolated cardiomyocytes. | |
glucose uptake, basal - brain | BasalGU-brain | (dpm/mg) | 1 to 1000000 | None | |
glucose uptake, basal - brown adipose tissue | BasalGU-BAT | (dpm/mg) | 1 to 1000000 | None | |
glucose uptake, basal - gastrocnemius | BasalGU-gastrocnemiu | (dpm/mg) | 1 to 1000000 | None | |
glucose uptake, basal - heart | BasalGU-heart | (dpm/mg) | -∞ to ∞ | None | |
glucose uptake, basal - liver | BasalGU-liver | (dpm/mg) | 1 to 1000000 | None | |
glucose uptake, basal - quadriceps | BasalGU-quadriceps | (dpm/mg) | 1 to 1000000 | None | |
glucose uptake, basal - red blood cells | BasalGU-RBC | (dpm/ml) | 1 to 1000000 | None | |
glucose uptake, basal - spleen | BasalGU-spleen | (dpm/mg) | 1 to 1000000 | None | |
glucose uptake, basal - white adipose tissue | BasalGU-WAT | (dpm/mg) | 1 to 1000000 | None | |
Glucose uptake, basal – kidney | BasalGU-kidney | (dpm/mg) | -∞ to ∞ | None | |
Glucose uptake, brain (glucose uptake brain) | GU, brain | (nmole/g/min) | -∞ to ∞ | None | |
glucose uptake, brown fat | glucose uptake brown | (nmole/g/min) | 0 to ∞ | None | |
glucose uptake, heart | glucose uptake heart | (nmole/g/min) | 0 to ∞ | None | |
glucose uptake, muscle | glucose uptake muscl | (nmole/g/min) | 0 to ∞ | None | |
glucose uptake, muscle -extensor digitorum longus | GU, EDG muscle | (nmole/g/min) | 0 to ∞ | None | |
glucose uptake, muscle -quadriceps | GU, QD muscle | (nmole/g/min) | 0 to ∞ | None | |
Glucose uptake, muscle-gastrocnemius | GU, GAS muscle | (nmole/g/min) | 0 to ∞ | None | |
glucose uptake, muscle-soleus | GU, SOL muscle | (nmole/g/min) | 0 to ∞ | None | |
glucose uptake, white adipose | glucose uptake white | (nmole/g/min) | 0 to ∞ | None | |
glucose uptake, white adipose -subcutaneous | glucose uptake, SWAT | (nmole/g/min) | 0 to ∞ | None | |
glucose uptake, white adipose-epididymal | glucose uptake, WAT | (nmole/g/min) | 0 to ∞ | None | |
glucose, arterial | None | (mg/dL) | -∞ to ∞ | None | |
glucose, basal | None | (mg/dL) | -∞ to ∞ | None | |
glucose, blood | blood glucose | (mg/dL) | 0 to ∞ | None | |
glucose, blood, arterial | None | | -∞ to ∞ | None | |
glucose, clamp average | None | (mg/dL) | -∞ to ∞ | None | |
glucose, plasma | plasma glucose | (mg/dL) | 0 to ∞ | None | |
glucose, rate of disappearance | Rd | (mg/kg/min) | -∞ to ∞ | None | |
glucose, urine | None | (mg/dL) | 0 to ∞ | None | |
glutamate | None | | 0 to ∞ | None | |
glutamine | None | | 0 to ∞ | None | |
glutamine dehydrogenase | GLDH | (U/L) | 0 to ∞ | None | |
glutamine rate of appearance in blood | None | | 0 to ∞ | None | |
glutamine rate of disappearance in blood | None | | 0 to ∞ | None | |
glutamine, blood, arterial | None | | 0 to ∞ | None | |
Glutathione disulfide, tissue | GSSG tissue | (nmol/mg) | 0 to 1000 | None | |
Glutathione Peroxidase Activity | GP Activity | (nmol/min/ml) | 0 to 5000 | None | |
Glutathione Peroxidase Activity - protein | GPA-protein | (nmol/min/mg protein) | 0 to 1000 | None | |
Glutathione Reductase Activity | GR Activity | (nmol/min/ml) | 0 to 5000 | None | |
Glutathione Reductase Activity - protein | GRA-protein | (nmol/min/mg protein) | 0 to 1000 | None | |
Glutathione, tissue | GSH tissue | (nmol/mg) | 0 to 1000 | None | |
glycerol | None | (µMol/min/g) | -∞ to ∞ | None | |
glycerol flux rate | glycerol FR | | -∞ to ∞ | None | |
glycerol fraction | glycerol fraction | | -∞ to ∞ | None | |
glycerol, plasma | None | (mg/dL) | 0 to 500 | None | |
glycerol, TG-bound new | TG-bound glycerol ne | (umol new/g tissue) | -∞ to ∞ | None | |
glycerol, TG-bound total | TG-bound glycerol to | (umol total/g tissue) | -∞ to ∞ | None | |
glycerol, total labeled | glycerol total label | (%) | 0 to 100 | None | |
glycine | None | | 0 to ∞ | None | |
glycogen concentration | glycogen conc | | 0 to ∞ | None | |
glycogen flux rate | glycogen FR | | -∞ to ∞ | None | |
glycogen fraction | glycogen fraction | | -∞ to ∞ | None | |
glycogen synthesis | None | (nmol/min/g) | -∞ to ∞ | None | |
glycogen, gastrocnemius | None | | -∞ to ∞ | None | |
glycogen, heart | None | | -∞ to ∞ | None | |
glycogen, liver | None | | 0 to ∞ | None | |
glycogen, muscle | None | | -∞ to ∞ | None | |
glycogen, superficial vastus lateralis | None | | 0 to ∞ | None | |
glycogen/lipid synthesis, whole body | None | (mg/kg/min) | -∞ to ∞ | None | |
glycogenolysis, rate | GLY | (µMol/min/g) | -∞ to ∞ | None | |
glycogenolytic rate | None | (mg/kg/min) | 0 to ∞ | None | |
glycolysis | None | (nmol/min/g) | -∞ to ∞ | None | |
glycolysis, whole body | None | (mg/kg/min) | -∞ to ∞ | None | |
Granulocyte colony stimulating factor | G-CSF | (pg/ml) | -∞ to ∞ | None | |
Growth Hormone | GH | (ng/ml) | 0 to ∞ | None | |
HbA1c | HbA1c | (%) | 0 to 100 | None | |
heart mass | cardiac muscle weigh | (g) | 0 to 3 | None | |
heart rate | HR | (bpm) | 0 to ∞ | Phenotypic Characterization of the Working Heart | |
heat | HEAT | (Kcal/hr) | -∞ to ∞ | None | |
heat (24hr) | heat - 24h | (Kcal/day) | -∞ to ∞ | None | |
heat (Dark Period) | HEAT-Dark | (Kcal/hr) | -∞ to ∞ | None | |
heat (Light Period) | HEAT-Light | (Kcal/hr) | -∞ to ∞ | None | |
hematocrit | Hct | | 0 to ∞ | None | |
hematocrit, arterial | None | (%) | -∞ to ∞ | None | |
Hematocrit, HCT | None | (%) | 0 to 100 | None | |
hepatic glucose production | HPG | (µMol/min/g) | -∞ to ∞ | None | |
hepatic glucose production, basal | None | (mg/kg/min) | -∞ to ∞ | None | |
Hepatic Glucose Production, clamp | None | (mg/kg/min) | -∞ to ∞ | None | |
hepatic insulin action | HIA | (%) | 0 to 100 | None | |
Histidine | None | | 0 to ∞ | None | |
Horseradish peroxidase (HRP) flux | HRP flux | (ng/cm2/h) | 0 to ∞ | UC Davis - Ex vivo assessment of barrier function-gut permeability | |
immunohistochemistry - BODIPY | IHC-BODIPY | (intensity (AU)) | 0 to ∞ | UC Davis - Immunohistochemistry BODIPY | |
immunohistochemistry - Factor VIII | IHC-Factor VIII | (density (AU)) | 0 to ∞ | UC Davis - Immunohistochemistry Factor VIII | |
immunohistochemistry - IBA1 | IHC-IBA1 | (density (AU)) | 0 to ∞ | UC Davis - Immunohistochemistry IBA1 | |
immunohistochemistry - Mitochondrial Marker | IHC-Mito Marker | (density (AU)) | 0 to ∞ | UC Davis - Immunohistochemistry Mitochondrial marker | |
Insulin 16.8 mM glucose | None | | 0 to ∞ | None | |
Insulin 16.8 mM glucose + IBMX | None | | 0 to ∞ | None | |
Insulin 5.6 mM glucose | None | | 0 to ∞ | None | |
Insulin 5.6 mM glucose + tollbutamide | None | | 0 to ∞ | None | |
insulin dose | None | (µMol/min/g) | -∞ to ∞ | None | |
insulin receptor substrate 1, phosphorylated | IRS-1 phosphorylated | (AU) | 0 to 10000 | None | |
insulin receptor substrate 1, total | IRS-1 total | (AU) | 0 to 10000 | None | |
insulin, arterial | None | (mg/dL) | -∞ to ∞ | None | |
insulin, basal | None | (ng/ml) | 0 to ∞ | None | |
insulin, blood | None | (ng/dl) | 0 to ∞ | None | |
insulin, clamp | None | (ng/ml) | 0 to ∞ | None | |
insulin, experimental | None | | -∞ to ∞ | None | |
insulin, plasma | None | (pg/ml) | 5 to 500000 | None | |
insulin, plasma, arterial | None | | 0 to ∞ | None | |
insulin, serum | S Insulin | | 0 to ∞ | None | |
Insulin-like Growth Factor-1 | IGF-1 | (ng/ml) | 0 to 1000 | None | |
inter-meal interval, average | avg IMI | (sec) | 0 to ∞ | None | |
inter-meal interval, average dark | avg dark-IMI | (sec) | 0 to ∞ | None | |
inter-meal interval, average light | avg light-IMI | (sec) | 0 to ∞ | None | |
Interferon gamma | IFNg | (pg/ml) | 0 to ∞ | None | |
Interferon gamma-induced protein 10 (CXCL-10) | IP-10 | (pg/ml) | 0 to ∞ | None | |
Interleukin 1 alpha | IL-1a | (pg/ml) | 0 to ∞ | None | |
Interleukin 1 beta | IL-1ß | (pg/ml) | 0 to ∞ | None | |
Interleukin 10 | IL-10 | (pg/ml) | 0 to ∞ | None | |
Interleukin 12 (p40) | IL-12 (p40) | (pg/ml) | 0 to ∞ | None | |
Interleukin 12 (p70) | IL-12 (p70) | (pg/ml) | 0 to ∞ | None | |
Interleukin 13 | IL-13 | (pg/ml) | 0 to ∞ | None | |
Interleukin 15 | IL-15 | (pg/ml) | 0 to ∞ | None | |
Interleukin 16 | IL-16 | (pg/ml) | 0 to ∞ | None | |
Interleukin 17A | IL-17A | (pg/ml) | 0 to ∞ | None | |
Interleukin 17E / Interleukin 25 | IL-17E/IL-25 | (pg/ml) | 0 to ∞ | None | |
Interleukin 2 | IL-2 | (pg/ml) | 0 to ∞ | None | |
Interleukin 20 | IL-20 | (pg/ml) | 0 to ∞ | None | |
Interleukin 21 | IL-21 | (pg/ml) | 0 to ∞ | None | |
Interleukin 22 | IL-22 | (pg/ml) | 0 to ∞ | None | |
Interleukin 23 | IL-23 | (pg/ml) | 0 to ∞ | None | |
Interleukin 27 | IL-27 | (pg/ml) | 0 to ∞ | None | |
Interleukin 28B | IL-28B | (pg/ml) | 0 to ∞ | None | |
Interleukin 3 | IL-3 | (pg/ml) | 0 to ∞ | None | |
Interleukin 33 | IL-33 | (pg/ml) | 0 to ∞ | None | |
Interleukin 4 | IL-4 | (pg/ml) | 0 to ∞ | None | |
Interleukin 5 | IL-5 | (pg/ml) | 0 to ∞ | None | |
Interleukin 6 | IL-6 | (pg/ml) | 0 to ∞ | None | |
Interleukin 7 | IL-7 | (pg/ml) | 0 to ∞ | None | |
Interleukin 8 homologue | KC | (pg/ml) | 0 to ∞ | None | |
Interleukin 9 | IL-9 | (pg/ml) | 0 to ∞ | None | |
Iron | Iron | (µg/dl) | 0 to 1000 | None | |
isoleucine | None | | 0 to ∞ | None | |
ketogenesis | ketogenesis | (µMol/min/g) | -∞ to ∞ | None | |
ketoisocaproic, blood, arterial | None | | 0 to ∞ | None | |
ketones, urine | urine ketones | | -∞ to ∞ | None | |
Kf, brain | None | | 0 to ∞ | None | |
Kf, diaphragm | None | | 0 to ∞ | None | |
Kf, diaphragms | None | | 0 to ∞ | None | |
Kf, gastrocnemius | None | | 0 to ∞ | None | |
Kf, heart | None | | 0 to ∞ | None | |
Kf, soleus | None | | 0 to ∞ | None | |
Kf, superficial vastus laterlis | None | | 0 to ∞ | None | |
Kg, adipose | None | (ml/100g/min) | 0 to ∞ | None | |
Kg, brain | None | (ml/100g/min) | 0 to ∞ | None | |
Kg, diaphragm | None | (ml/100g/min) | 0 to ∞ | None | |
Kg, gastrocnemius | None | (ml/100g/min) | 0 to ∞ | None | |
Kg, heart | None | (ml/100g/min) | 0 to ∞ | None | |
Kg, soleus | None | (ml/100g/min) | 0 to ∞ | None | |
Kg, superficial vastus lateralis | None | (ml/100g/min) | 0 to ∞ | None | |
Kg, vastus lateralis | None | (ml/100g/min) | -∞ to ∞ | None | |
kidney glomerular size | GlomerularSize | (µm²) | -∞ to ∞ | None | |
kidney matrix area | kidney matrix area | (µm²) | -∞ to ∞ | None | |
kidney percent matrix | kidney percent matri | (%) | 0 to 100 | None | |
kidney, long-axis area | None | (cm) | 0 to ∞ | None | |
kidney, long-axis area, right | right kidney LAArea | (cm) | 0 to ∞ | None | |
kidney, long-axis circle | None | (cm) | 0 to ∞ | None | |
kidney, long-axis circle, right | right kidney LACircl | (cm) | 0 to ∞ | None | |
kidney, long-axis HGT | None | (cm) | 0 to ∞ | None | |
kidney, long-axis HGT, right | right kidney LAHGT | (cm) | 0 to ∞ | None | |
kidney, long-axis LGT | None | (cm) | 0 to ∞ | None | |
kidney, long-axis LGT, right | right kidney LALGT | (cm) | 0 to ∞ | None | |
kidney, short-axis area, right | right kidney SAArea | (cm) | 0 to ∞ | None | |
kidney, short-axis circle | None | (cm) | 0 to ∞ | None | |
kidney, short-axis circle, right | right kidney SACircl | (cm) | 0 to ∞ | None | |
kidney, short-axis HGT | None | (cm) | 0 to ∞ | None | |
kidney, short-axis HGT, right | right kidney SAHGT | (cm) | 0 to ∞ | None | |
kidney, short-axis LGT | None | (cm) | 0 to ∞ | None | |
kidney, short-axis WDT | None | (cm) | 0 to ∞ | None | |
kidney, short-axis WDT, right | right kidney SAWDT | (cm) | 0 to ∞ | None | |
L-Lactate | L-Lactate | (mg/dL) | 0 to 100 | None | |
lactate | lactate | (mmol/L) | 1 to 50 | None | |
lactate dehydrogenase | lactate dehydrogenas | (U/L) | 0 to ∞ | None | |
latency | latency | (sec) | 0 to 90 | UC Davis - Morris Water Maze | |
lean body mass | None | (g) | -∞ to ∞ | None | |
lean tissue mass | None | (g) | -∞ to ∞ | None | |
lean tissue, % | % lean mass | (%) | 0 to 100 | None | |
left atrial end diastolic area | LAEDA | (mm²) | -∞ to ∞ | None | |
left atrial end systolic area | LAESA | (mm²) | -∞ to ∞ | None | |
left atrial fractional area change, % | LAFAC | (%) | -∞ to ∞ | None | |
left atrial pressure | None | (mmHg) | -∞ to ∞ | None | |
left ventricle anterior wall thickness, end diastolic | LVAWT-end diastolic | (mm) | 0 to ∞ | None | |
left ventricle chamber diameter end diastolic | None | (mm) | -∞ to ∞ | None | |
left ventricle chamber diameter end systolic | None | (mm) | -∞ to ∞ | None | |
left ventricle interior diameter end diastolic | LVID-end diastolic | | 0 to ∞ | None | |
left ventricle interior diameter end systolic | LVID-end systoloic | (mm) | 0 to ∞ | None | |
left ventricle internal diameter end-diastole | None | (cm) | 0 to ∞ | None | |
left ventricle internal diameter end-systole | None | (cm) | 0 to ∞ | None | |
left ventricle mass | None | (g) | 0 to ∞ | None | |
left ventricle posterior wall thickness end diastolic | LVPWT-end diastolic | (mm) | -∞ to ∞ | None | |
left ventricle posterior wall thickness end systolic | LVPWT-end systolic | (mm) | -∞ to ∞ | None | |
left ventricle posterior wall thickness end-diastole | LVPWT-end diaastole | (cm) | 0 to ∞ | None | |
left ventricle posterior wall thickness end-systole | LVPWT-end systole | (cm) | 0 to ∞ | None | |
left ventricle septal wall thickness end-diastole | LVSWT-end diastole | (cm) | 0 to ∞ | None | |
left ventricle septal wall thickness end-systole | LVSWT-end systole | (cm) | 0 to ∞ | None | |
left ventricle septum wall thickness end diastolic | LVSWT-end diastole | (mm) | -∞ to ∞ | None | |
left ventricle septum wall thickness end systolic | LVSWT-end systolic | (mm) | -∞ to ∞ | None | |
left ventricle volume - diastolic | LV Vol-d | (µl) | 0 to ∞ | None | |
left ventricle volume - systolic | LV Vol-s | (µl) | 0 to ∞ | None | |
left ventricular minute work | LV Minute work | (mEq/L) | -∞ to ∞ | None | |
leptin | None | (ng/dl) | -∞ to ∞ | None | |
leptin (RIA) | Leptin | | 0 to ∞ | None | |
leucine | None | | 0 to ∞ | None | |
leucine appearance reciprocal model rate | None | | 0 to ∞ | None | |
leucine disappearance rate | None | | 0 to ∞ | None | |
leucine, blood, arterial | None | | 0 to ∞ | None | |
Leukemia inhibitory factor | LIF | (pg/ml) | 0 to ∞ | None | |
linoleate, tissue | linoleate (tissue) | (mg/g tissue) | -∞ to ∞ | None | |
lipids, blood | None | (mg/dL) | 0 to ∞ | None | |
lipids, tissue | lipids tissue | (%) | 0 to ∞ | None | |
lipopolysaccharide binding protein (LBP) concentration | LBP conc | (µg/ml) | 0 to ∞ | UC Davis - Lipoprotein Binding Protein (LBP)-Endotoxemia Assay | |
lipoprotein, intermediate density | None | | 0 to ∞ | None | |
lipoproteins, alpha | None | (%) | -∞ to ∞ | None | |
lipoproteins, beta | None | (%) | -∞ to ∞ | None | |
lipoproteins, LDL | None | | 0 to ∞ | None | |
lipoproteins, pre-beta | None | (%) | -∞ to ∞ | None | |
liver mass | Liver Wt | (g) | 0 to 6 | None | |
LPS-induced CXC chemokine | LIX | (pg/ml) | 0 to ∞ | None | |
lymph flow | lymph flow | (ml/hr) | -∞ to ∞ | None | |
Lysine | None | | 0 to ∞ | None | |
Macrophage colony stimulating factor | M-CSF | (pg/ml) | 0 to ∞ | None | |
macrophage colony stimulating factor, granulocyte | GM-CSf | (pg/ml) | -∞ to ∞ | None | |
Macrophage inflammatory protein 2-alpha (CXCL2) | MIP-2/RANTES | (pg/ml) | 0 to ∞ | None | |
Macrophage inflammatory protein 3-alpha (CCL20) | MIP-3a | (pg/ml) | 0 to ∞ | None | |
Macrophage inflammatory protein 3-beta (CCL19) | MIP-3ß | (pg/ml) | 0 to ∞ | None | |
Macrophage inflammatory protein alpha (CCL3) | MIP-1a | (pg/ml) | 0 to ∞ | None | |
Macrophage inflammatory protein beta (CCL4) | MIP-1ß | (pg/ml) | 0 to ∞ | None | |
Macrophage-derived chemokine (CCL22) | MDC | (pg/ml) | 0 to ∞ | None | |
magnesium | None | (mEq/L) | -∞ to ∞ | None | |
mammary gland mass | Mammary wt | (g) | 0 to 3 | None | |
Max Alternations | MA | (TPD) | -∞ to ∞ | None | |
maze errors | maze errors | | 1 to 15 | UC Davis - Radial Arm Water Maze | |
meal duration (Avg) - Active Eating Time | avg meal dur AET | (sec) | 0 to ∞ | None | |
meal duration (total) | total meal duration | (sec) | 0 to ∞ | None | |
meal duration, average dark | avg dark-meal dur | (sec) | 0 to ∞ | None | |
meal duration, average light | avg light-meal dur | (sec) | 0 to ∞ | None | |
meal size (Avg) | avg meal size | (g) | 0 to ∞ | None | |
meal size, average dark | avg dark-meal size | (g) | 0 to ∞ | None | |
meal size, average light | avg light-meal size | (g) | 0 to ∞ | None | |
meals, number | num meals | | -∞ to ∞ | None | |
meals, number dark | dark-num meals | | -∞ to ∞ | None | |
meals, number light | light-num meals | | 0 to ∞ | None | |
mesangial index | PAS | (%PAS/glom) | 0 to 100 | None | |
methionine | None | | 0 to ∞ | None | |
Monocyte chemotactic protein-1 (CCL2) | MCP-1 | (pg/ml) | 0 to ∞ | None | |
Monocyte chemotactic protein-5 (CCL12) | MCP-5 | (pg/ml) | 0 to ∞ | None | |
Monokine induced by gamma interferon (CXCL9) | MIG | (pg/ml) | 0 to ∞ | None | |
muscle mass, skeletal | skeletal muscle weig | (g) | 0 to 3 | None | |
Muscle mass, skeletal GAS-L muscle weight | GAS-L MW | | -∞ to ∞ | None | |
Muscle mass, skeletal GAS-R muscle weight | GAS-R MW | | -∞ to ∞ | None | |
Muscle mass, skeletal QD-L muscle weight | QD-L MW | (g) | 0 to ∞ | None | |
Muscle mass, skeletal QD-R muscle weight | QD-R MW | (g) | 0 to ∞ | None | |
Muscle mass, skeletal TA-L muscle weight | TA-L MW | | -∞ to ∞ | None | |
Muscle mass, skeletal TA-R muscle weight | TA-R MW | (g) | 0 to ∞ | None | |
NEFA | FFA | | -∞ to ∞ | None | |
NEFA oxidation | None | (umol/min/g) | -∞ to ∞ | None | |
NEFA oxidation, free | FFA OX | (µMol/min/g) | -∞ to ∞ | None | |
NEFA, arterial | None | | 0 to ∞ | None | |
NEFA, in chylomicrons | FFA in CM | (% wt/wt) | -∞ to ∞ | None | |
NEFA, plasma | None | | -∞ to ∞ | None | |
NEFA, plasma, arterial | apNEFA | | -∞ to ∞ | None | |
NEFA, plasma, arterial, clamp | None | | -∞ to ∞ | None | |
NEFA, plasma, arterial, fatty acids | None | | -∞ to ∞ | None | |
NEFA, short-chain | None | (µg/mg) | 0 to ∞ | None | |
neointimal hyperplasia | Neo Hyperplasia | (µm²) | 0 to ∞ | None | |
non-esterified free fatty acids | NEFA | (µmol/l) | 0 to ∞ | None | |
norepinephrine, plasma, arterial | None | | 0 to ∞ | None | |
Novel exploration-percent | Novel exploration-pe | (%) | 0 to 100 | None | |
Number of arm entries | NAE | (TPD) | -∞ to ∞ | None | |
octanoate oxidation | OCT OX | (µMol/min/g) | -∞ to ∞ | None | |
oleate, tissue | oleate (tissue) | (mg/g tissue) | -∞ to ∞ | None | |
osmolality | None | (fL) | -∞ to ∞ | None | |
oxygen consumption | VO2 | (O2/kg/hr) | -∞ to ∞ | None | |
oxygen consumption (Dark Period) | VO2-D | (O2/kg/hr) | -∞ to ∞ | None | |
oxygen consumption (Light Period) | VO2-L | (O2/kg/hr) | -∞ to ∞ | None | |
palmitate, TG-bound new | TG-bound plamitate n | (umol new/g tissue) | -∞ to ∞ | None | |
palmitate, TG-bound total | TG-bound palmitate t | (umol total/g tissue) | -∞ to ∞ | None | |
palmitate, TG-bound, newly sythesized | TG-bound palmitate N | (%) | 0 to 100 | None | |
palmitate, tissue | palmitate (tissue) | (mg/g tissue) | -∞ to ∞ | None | |
PEPCK | None | (µMol/min/g) | -∞ to ∞ | None | |
Permeability | Ki | (min^-1) | 0 to 1 | None | |
phenylalanine | None | | 0 to ∞ | None | |
phenylalanine appearance in blood rate | None | | 0 to ∞ | None | |
phenylalanine disappearance rate | None | | 0 to ∞ | None | |
phenylalanine, blood, arterial | None | | 0 to ∞ | None | |
phosphate, blood | None | (mg/dL) | 0 to ∞ | None | |
phosphate, blood, inorganic | blood inorganic phos | (mg/dL) | 0 to ∞ | None | |
phosphate, urine | urine inorganic phos | (mg/dL) | 0 to ∞ | None | |
Phosphatidyl choline | None | (µg/mg) | 0 to ∞ | None | |
phosphatidyl ethanolamine | None | (µg/mg) | 0 to ∞ | None | |
Phosphatidyl serine | None | (µg/mg) | 0 to ∞ | None | |
phosphoenolpyruvate | None | (µMol/min/g) | -∞ to ∞ | None | |
Phosphoenolpyruvate carboxykinase flux rate | PEPCK FR | | -∞ to ∞ | None | |
phosphoenolpyruvate flux rate | PEP FR | | -∞ to ∞ | None | |
phosphoenolpyruvate fraction | PEP fraction | | -∞ to ∞ | None | |
phospholipid | None | (mg/dL) | -∞ to ∞ | None | |
phospholipid fatty acids | None | (%) | 0 to 100 | None | |
phospholipids, chylomicrons | PL-CM | (% wt/wt) | -∞ to ∞ | None | |
Plasma C14, Specific Activity | SA | (dpm/mg) | -∞ to ∞ | None | |
potassium, blood | None | | 0 to ∞ | None | |
potassium, urine | urine postassium | (µmol/l) | 0 to ∞ | None | |
pressure development, maximal rate | None | | -∞ to ∞ | None | |
Prolactin | PRL | (ng/ml) | 0 to ∞ | None | |
proline | None | (µmol/l) | -∞ to ∞ | None | |
protein | None | (g/dL) | -∞ to ∞ | None | |
Protein Carbonyl | Protein Carbonyl | (nmol/ml) | 0 to 1000 | None | |
Protein Carbonyl - protein | P Carbonyl - protein | (nmol/mg) | 0 to 1000 | None | |
Protein concentration, adipose, epididymal | protein conc WAT | (µg/ml) | -∞ to ∞ | None | |
Protein concentration, liver | protein conc liver | (µg/ml) | -∞ to ∞ | None | |
Protein concentration, muscle, gastrocnemius | protein conc GAS | (µg/ml) | -∞ to ∞ | None | |
protein, chylomicrons | Protein-CM | (% wt/wt) | -∞ to ∞ | None | |
protein, total blood | None | | 0 to ∞ | None | |
pulse | None | (bpm) | 0 to ∞ | None | |
pyruvate cycling flux rate | PC FR | | -∞ to ∞ | None | |
pyruvate oxidation | PYRV OX | (ng/ml) | -∞ to ∞ | None | |
relaxation, maximal rate | None | | -∞ to ∞ | None | |
Resistin | None | (ng/ml) | -∞ to ∞ | None | |
Respiratory Control | RC | | -∞ to ∞ | Evaluation of Mitochondrial Function | |
respiratory exchange ratio | RQ | | -∞ to ∞ | None | |
respiratory exchange ratio (Dark Period) | RER-D | | -∞ to ∞ | None | |
respiratory exchange ratio (Light Period) | RER-L | | 0 to ∞ | None | |
respiratory exchange ratio, maximum | RQ-Max | (AU) | 0.6 to 1.2 | None | |
respiratory exchange ratio, minimum | RQ-Min | (AU) | 0.6 to 1.2 | None | |
Rg, adipose | None | (umol/100g/min) | 0 to ∞ | None | |
Rg, brain | None | (umol/100g/min) | 0 to ∞ | None | |
Rg, diaphragm | None | (umol/100g/min) | 0 to ∞ | None | |
Rg, gastrocnemeous | None | (umol/100g/min) | 0 to ∞ | None | |
Rg, heart | None | (umol/100g/min) | 0 to ∞ | None | |
Rg, soleus | None | (umol/100g/min) | 0 to ∞ | None | |
Rg, vastus lateralis | None | (umol/100g/min) | 0 to ∞ | None | |
Sample Weight | sample weight | (mg) | -∞ to ∞ | None | |
satiety ratio | satiety ratio | | 0 to ∞ | None | |
satiety ratio, dark | dark-satiety ratio | | -∞ to ∞ | None | |
satiety ratio, light | light-satiety ratio | | 0 to ∞ | None | |
serines | None | | 0 to ∞ | None | |
Serum Amyloid A1 (SAA1) | SAA1 | (ng/ml) | 0 to 10000000 | None | |
serum glutamic pyruvic transaminase | None | | 0 to ∞ | None | |
sodium, blood | None | | 0 to ∞ | None | |
sodium, urine | urine sodium | (µmol/l) | 0 to ∞ | None | |
Somatostatin | Somatostatin | (pg/ml) | -∞ to ∞ | None | |
sphingomyelin | None | (µg/mg) | 0 to ∞ | None | |
sterate | sterate (tissue) | (mg/g tissue) | -∞ to ∞ | None | |
sterol synthesis | None | | -∞ to ∞ | None | |
Stomach Mass | Stomach Mass | (g) | 0 to 5 | None | |
Superoxide Dismutase Activity | SOD Actvity | (u/ml) | 0 to 5000 | None | |
Superoxide Dismutase Activity - protein | SOD Activity - prot | (U/mg protein) | 0 to 5000 | None | |
TAQ | A | | -∞ to ∞ | None | |
TCA cycle flux | VTCA | (µMol/min/g) | -∞ to ∞ | None | |
temperature, body | body temp | (°C) | 25 to 45 | None | |
temperature, environmental | ENV TEMP | (°C) | 3 to 40 | None | |
Thioredoxin | Trx-protein | (ng/mg) | 0 to 10000 | None | |
Thioredoxin Reductase Activity | TrxR-protein | (umol/min/mg) | 0 to 10 | None | |
threonine | None | | 0 to ∞ | None | |
Thrombopoeitin | THPO | (pg/ml) | 0 to 10000 | UC Davis - ELISA Protocol | |
Thymus and activation-regulated (CCL17) | TARC | (pg/ml) | 0 to ∞ | None | |
Thyroid-stimulating hormone | TSH | (ng/ml) | 0 to ∞ | None | |
Thyrotropin-releasing hormone | TRH | (pg/ml) | 0 to ∞ | None | |
Thyroxine | T4 | (ng/ml) | 0 to ∞ | None | |
Time in Open Field Zone | Time in OPZ | (min) | 0 to 20 | None | |
time in platform/border zone | time in zone | (sec) | 0 to 90 | UC Davis - Morris Water Maze | |
Time to Peak Pressure | None | (10^3/mm3) | -∞ to ∞ | None | |
tissue area | tissue area | (cm²) | -∞ to ∞ | None | |
Tissue-inhibitor of metalloproteinases | TIMP-1 | (pg/ml) | 0 to ∞ | None | |
total activity | None | | 0 to ∞ | None | |
total body weight | None | (g) | -∞ to ∞ | None | |
total distance | TD | (m) | 0 to 50000 | None | |
Total distance traveled | TDT | (cm) | -∞ to ∞ | None | |
total tissue mass | TTM | (g) | -∞ to ∞ | None | |
Transforming growth factor beta 1 | TGF-B1 | (ng/ml) | 0 to 1000 | None | |
triglyceride in LDL and VLDL | TG in LDL/VLDL | (mg/dL) | 0 to 2000 | None | |
triglyceride pool enrichment | TG POOL | | -∞ to ∞ | None | |
triglyceride remaining in intestinal lumen | TG in IL | (%) | -∞ to ∞ | None | |
triglyceride remaining in intestinal mucosa | TG in IM | (%) | -∞ to ∞ | None | |
triglyceride transported in lymph | TG in Lymph | (%) | -∞ to ∞ | None | |
triglyceride, CM | TG in CM | (mg/dL) | 0 to 10000 | None | |
triglyceride, fatty acids | TGFA | (%) | 0 to 100 | None | |
triglyceride, fractional clearance rate | TG FCR | (min) | -∞ to ∞ | None | |
triglyceride, HDL | TG in HDL | (mg/dL) | -∞ to ∞ | None | |
triglyceride, hepatic uptake | Hepatic TG uptake | (% wt/wt) | -∞ to ∞ | None | |
triglyceride, LDL | TG in LDL | (mg/dL) | -∞ to ∞ | None | |
triglyceride, newly synthesized | new triglyceride | (%) | 0 to 100 | None | |
triglyceride, splenic uptake | Splenic TG uptake | (U/L) | -∞ to ∞ | None | |
triglyceride, TG-bound new | TG-bound triglycerid | (umol new/g tissue) | -∞ to ∞ | None | |
triglyceride, TG-bound total | TG-bound triglycerid | (umol total/g tissue) | -∞ to ∞ | None | |
triglyceride, vLDL | TG in VLDL | (mg/dL) | -∞ to ∞ | None | |
triglycerides | TG | (mg/dL) | -∞ to ∞ | None | |
triglycerides in organ through extraction & determination | None | (U/L) | -∞ to ∞ | None | |
triglycerides, tissue | TG (tissue) | (mg/g tissue) | -∞ to ∞ | None | |
Triglycerides, tissue, umol per g | TG (tissue) | (umol total/g tissue) | -∞ to ∞ | None | |
Triiodothyronine | T3 | (pg/ml) | 0 to ∞ | None | |
Troponin I (cardiac) | Troponin I - cardiac | (ng/ml) | 0 to 1000 | None | |
Troponin T | Troponin T | (pg/ml) | 0 to 1000 | None | |
Tumor necrosis factor alpha | TNFa | (pg/ml) | 0 to ∞ | None | |
tyrosines | None | | 0 to ∞ | None | |
unesterified cholesterol | None | (µg/mg) | 0 to ∞ | None | |
unesterified fatty acids | None | (µg/mg) | 0 to ∞ | None | |
urea nitrogen, blood | BUN | (mg/dL) | 0 to ∞ | None | |
Uric Acid | Uric Acid | (mg/dL) | 0 to 100 | None | |
urine output | urine output | (ml) | -∞ to ∞ | None | |
urine pH | urine pH | | 0 to 14 | None | |
valine | None | | 0 to ∞ | None | |
Vascular endothelial growth factor | VEGF | (pg/ml) | 0 to ∞ | None | |
VCO2 (Dark) | VCO2-D | (CO2/kg/hr) | 0 to ∞ | None | |
VCO2 (Light) | VCO2-L | (CO2/kg/hr) | 0 to ∞ | None | |
VCO2 30 Min Exercise | None | | 0 to ∞ | None | |
VCO2 basal | None | | 0 to ∞ | None | |
VCO2 exhaustion | None | | 0 to ∞ | None | |
VCO2 max | None | | 0 to ∞ | None | |
VCO2 rate | VCO2 rate | (ml/hr/kg) | 0 to ∞ | None | |
Velocity run | Velocity run | (m/min) | 0 to 50 | None | |
VO2 (Dark) | VO2-D | (O2/kg/hr) | 0 to ∞ | None | |
VO2 (Light) | VO2-L | (O2/kg/hr) | 0 to ∞ | None | |
VO2 30 min exercise | None | | 0 to ∞ | None | |
VO2 basal | None | | 0 to ∞ | None | |
VO2 Exhaustion | None | | 0 to ∞ | None | |
VO2 max | None | | 0 to ∞ | None | |
VO2 rate | VO2 rate | (ml/hr/kg) | 0 to ∞ | None | |
VO2, maximum | None | | -∞ to ∞ | None | |
water intake | water intake | (ml/kg/hr) | 0 to 4 | None | |
wheel running day | None | | 0 to ∞ | None | |
Work Duration | None | (min) | 0 to ∞ | None | |
WR max | None | | 0 to ∞ | None | |
@NationalMMPC
Mouse Phenotyping